Mitigation of inflammatory bowel disease-related osteoporosis by oxyberberine: Insights into the RANKL/NF-κB signaling pathway
PMID: 38574627
Source: Biomed Pharmacother
Publication date:
2025-07-24
Year:
2024
Abstract
NULL